Clinical Trial Details

Overview

Research Study Summary

Do you miss that loving feeling? A hysterectomy can affect your sexual desire.

Purpose

If you’re a woman at least 30 years of age, have had a hysterectomy, and are experiencing a decrease in sexual desire, you may qualify for medical research study. The study will evaluate LibiGel®, an investigational, medication for Hypoactive Sexual Desire Disorder (HSSD). Local physicians are enrolling participants now.

  • All Study-related care is provided at no cost.
  • Financial compensation may be provided

Inclusion Criteria:

  • Must be between the ages of 30 to 65 years
  • Must have undergone hysterectomy and bilateral salpingo-oophorectomy
  • Must be taking a stable dose of estrogen therapy

Exclusion Criteria:

  • A history of allergic reactions to androgens (oral or patch), topical alcohol, or any component of the formulation
  • Any systemic skin diseases or local skin abnormalities in the area of application
  • Diagnosed with another primary female sexual dysfunction (e.g., Sexual Aversion Disorder, Female Sexual Arousal Disorder).
  • A medical condition that could affect or interfere with sexual function
  • Using a systemic transdermal gel or cream estrogen therapy.

To Learn more

CW ID: 165878
Date Last Changed: July 23, 2013

Clinical Trial Snapshot

Phase
2
Gender
Female
Age
30 to 65 Years
Overall Status
Recruiting
Facility Type
N/A

Contact

Diablo Clinical Research
2255 Ygnacio Valley Rd STE M
Walnut Creek, CA 94598
Phone: 925-930-7267

View Map

Research Center Information:

Diablo Clinical Research

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.